CoChat

Simultaneous Loss of Both Atypical Protein Kinase C Genes in the Intestinal Epithelium Drives Serrated Intestinal Cancer by Impairing Immunosurveillance

Open access
Nakanishi, Yuki, Duran, Angeles, L’Hermitte, Antoine, Shelton, Phillip M., Nakanishi, Naoko, Reina-Campos, Miguel, Huang, Jianfeng, Soldevila, Ferran, Baaten, Bas J.G., Tauriello, Daniele V.F., Castilla, Elias A., Bhangoo, Munveer S., Bao, Fei, Sigal, Darren, Diaz-Meco, Maria T., Moscat, Jorge · 2018 · Immunity
Cited by 60

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

&NA; Serrated adenocarcinoma, an alternative pathway for colorectal cancer (CRC) development, accounts for 15%–30% of all CRCs and is aggressive and treatment resistant. We show that the expression of atypical protein kinase C &zgr; (PKC&zgr;) and PKC&lgr;/&igr; was reduced in human serrated tumors. Simultaneous inactivation of the encoding genes in the mouse intestinal epithelium resulted in spontaneous serrated tumorigenesis that progressed to advanced cancer with a strongly reactive and immunosuppressive stroma. Whereas epithelial PKC&lgr;/&igr; deficiency led to immunogenic cell death and the infiltration of CD8+ T cells, which repressed tumor initiation, PKC&zgr; loss impaired interferon and CD8+ T cell responses, which resulted in tumorigenesis. Combined treatment with a TGF‐&bgr; receptor inhibitor plus anti‐PD‐L1 checkpoint blockade showed synergistic curative activity. Analysis of human samples supported the relevance of these kinases in the immunosurveillance defects of human serrated CRC. These findings provide insight into avenues for the detection and treatment of this poor‐prognosis subtype of CRC. Graphical Abstract Figure. No caption available. HighlightsAtypical protein kinase C (aPKC) expression is reduced in human serrated tumorsDeletion of both aPKCs in intestinal epithelium causes spontaneous serrated tumorsaPKC‐deficient tumors display immunosuppression and stromal activationLoss of PKC&zgr; impairs the CD8+ T cell response, triggering serrated tumor initiation &NA; Serrated adenocarcinomas are an aggressive and treatment‐resistant form of colorectal cancer. Nakanishi et al. show that expression of atypical PKCs is reduced in human serrated tumors and that their loss results in spontaneous serrated tumorigenesis with stromal activation and immunosuppression in mice. The simultaneous inhibition of stromal activation combined with anti‐PD‐L1 showed synergistic therapeutic potential.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2018.09.013

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 60

Metadata

Authors
Nakanishi, Y., Duran, A., L’Hermitte, A., Shelton, P. M., Nakanishi, N., Reina-Campos, M., Huang, J., Soldevila, F., Baaten, B. J. G., Tauriello, D. V. F., Castilla, E. A., Bhangoo, M. S., Bao, F., Sigal, D., Diaz-Meco, M. T., & Moscat, J.
Venue
Immunity
Publisher
Elsevier BV
Published
2018-12
Volume
49
Issue
6
Pages
1132-1147.e7
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2905189746
Cited by
60
References
9
FWCI
1.94
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.